Janus Henderson Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $140K | Hold |
|
|||||
|
2024
Q3 | $187K | Hold |
|
|||||
|
2024
Q2 | $281K | Sell |
|
|||||
|
2024
Q1 | $490K | Hold |
|
|||||
|
2023
Q4 | $567K | Sell |
|
|||||
|
2023
Q3 | $539K | Buy |
|
|||||
|
2023
Q2 | $1.23M | Sell |
|
|||||
|
2023
Q1 | $17.6M | Sell |
|
|||||
|
2022
Q4 | $23.6M | Sell |
|
|||||
|
2022
Q3 | $57.3M | Buy |
|
|||||
|
2022
Q2 | $24.8M | Sell |
|
|||||
|
2022
Q1 | $34.1M | Buy |
|
|||||
|
2021
Q4 | $41.5M | Sell |
|
|||||
|
2021
Q3 | $46.6M | Sell |
|
|||||
|
2021
Q2 | $94.3M | Sell |
|
|||||
|
2021
Q1 | $140M | Sell |
|
|||||
|
2020
Q4 | $171M | Buy |
|
|||||
|
2020
Q3 | $99M | Buy |
|
|||||
|
2020
Q2 | $60.7M | Buy |
|
|||||
|
2020
Q1 | $39.9M | Sell |
|
|||||
|
2019
Q4 | $174M | Buy |
|
|||||
|
2019
Q3 | $283M | Buy |
|
|||||
|
2019
Q2 | $343M | Buy |
|
|||||
|
2019
Q1 | $265M | Buy |
|
|||||
|
2018
Q4 | $29.6M | Buy |
|
|||||
|
2018
Q3 | $37.4M | Buy |
|
|||||
|
2018
Q2 | $27.7M | Sell |
|
|||||
|
2018
Q1 | $29.7M | Sell |
|
|||||
|
2017
Q4 | $32.5M | Buy |
|